Sang-Kyung Lee

A single siRNA suppresses fatal encephalitis induced by two different flaviviruses.

NFAT5 regulates HIV-1 in primary monocytes via a highly conserved long terminal repeat site.

Effective suppression of HIV-1 by artificial bispecific miRNA targeting conserved sequences with tolerance for wobble base-pairing.

T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice.

Controlled delivery of heat shock protein using an injectable microsphere/hydrogel combination system for the treatment of myocardial infarction.

Conditional RNAi: towards a silent gene therapy.

The heat shock protein 27 (Hsp27) operates predominantly by blocking the mitochondrial-independent/extrinsic pathway of cellular apoptosis.

Preparation and characterization of chitosan/polyguluronate nanoparticles for siRNA delivery.

Delivering antiviral siRNA into human T-cells: New approaches in RNAi-based HIV therapy.

Targeted delivery of small interfering RNA to human dendritic cells to suppress dengue virus infection and associated proinflammatory cytokine production.

The effect of spacer arm length of an adhesion ligand coupled to an alginate gel on the control of fibroblast phenotype.

Facile control of porous structures of polymer microspheres using an osmotic agent for pulmonary delivery.

Blockade of the Wnt/β-catenin pathway attenuates bleomycin-induced pulmonary fibrosis.

Arginine-engrafted biodegradable polymer for the systemic delivery of therapeutic siRNA.

Oligoarginine-modified chitosan for siRNA delivery.

Single chain variable fragment CD7 antibody conjugated PLGA/HDAC inhibitor immuno-nanoparticles: developing human T cell-specific nano-technology for delivery of therapeutic drugs targeting latent HIV.

Cell-specific siRNA delivery by peptides and antibodies.

T cell-specific siRNA delivery using antibody-conjugated chitosan nanoparticles.

Preparation and characterization of nonaarginine-modified chitosan nanoparticles for siRNA delivery.

Sequential delivery of TAT-HSP27 and VEGF using microsphere/hydrogel hybrid systems for therapeutic angiogenesis.

Injectable microsphere/hydrogel hybrid system containing heat shock protein as therapy in a murine myocardial infarction model.

Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein and guide RNA.

Effective gene delivery into human stem cells with a cell-targeting Peptide-modified bioreducible polymer.

Attachment of cell-binding ligands to arginine-rich cell-penetrating peptides enables cytosolic translocation of complexed siRNA.

Liver-targeted cyclosporine A-encapsulated poly (lactic-co-glycolic) acid nanoparticles inhibit hepatitis C virus replication.

Silencing CCR2 in Macrophages Alleviates Adipose Tissue Inflammation and the Associated Metabolic Syndrome in Dietary Obese Mice.

Trileucine residues in a ligand-CPP-based siRNA delivery platform improve endosomal escape of siRNA.

Small Interfering RNA-Mediated Control of Virus Replication in the CNS Is Therapeutic and Enables Natural Immunity to West Nile Virus.

Intranasal delivery of a Fas-blocking peptide attenuates Fas-mediated apoptosis in brain ischemia.